Vivos Therapeutics (VVOS) EPS (Basic) Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 17.98% |
| 10 | Vivos Therapeutics | 4.95 Mn | 3.15 Mn | 2.95 Mn | 59.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.66% |
| Dec 31, 2025 | -367.72% |
| Sep 30, 2025 | -325.40% |
| Jun 30, 2025 | -306.18% |
| Mar 31, 2025 | 58.47% |
| Dec 31, 2024 | 59.58% |
| Sep 30, 2024 | 60.76% |
| Jun 30, 2024 | 50.31% |
| Mar 31, 2024 | 29.57% |
| Dec 31, 2023 | 32.87% |
| Sep 30, 2023 | 24.92% |
| Jun 30, 2023 | -11.50% |
| Mar 31, 2023 | 32.83% |